AstraZeneca Pharmaceuticals LP
FDA inspection history in Redwood City, California, 2016
- 1
- Form 483
Every document, by year
- Form 483
2016: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2016One Form 483, at Redwood City, California.
Cited most
Across all AstraZeneca Pharmaceuticals observations on file
- 21 CFR 211.22Responsibilities of quality control unit2
- 21 CFR 211.28Personnel responsibilities2
- 21 CFR 211.125Labeling issuance1
- 21 CFR 211.160General requirements1
- 21 CFR 211.42Design and construction features1
The complete AstraZeneca Pharmaceuticals file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Redwood City, California
One Form 483 · 2016
Latest: Form 483, Feb 26, 2016 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2016-02-26 | 483 Form 483 | Redwood City, California | — | $99 |
Investigators on these documents
FEI number 3011389428 · most recent document Feb 26, 2016
About AstraZeneca Pharmaceuticals LP
How many FDA Form 483s has AstraZeneca Pharmaceuticals LP received?
FDA Intel has 1 Form 483 on file for AstraZeneca Pharmaceuticals LP; the most recent is dated Feb 26, 2016.
When was AstraZeneca Pharmaceuticals LP last inspected by FDA?
The most recent FDA inspection document on file for AstraZeneca Pharmaceuticals LP is a Form 483 dated Feb 26, 2016, for the site in Redwood City, California.
What did FDA cite at AstraZeneca Pharmaceuticals LP?
The regulations cited most in the observations on file for AstraZeneca Pharmaceuticals LP are 21 CFR 211.22 (Responsibilities of quality control unit), 2 times; 21 CFR 211.28 (Personnel responsibilities), 2 times; 21 CFR 211.125 (Labeling issuance), 1 time.